Market Place
Sourcing Support
Sunshine Lake Generic Alogliptin Receives Tentative Approval in US
09 Jan 2021 //
FDA
MSN`s Generic Alogliptin Receives Tentative Approval in US
29 Jan 2019 //
FDA
Alembic Pharms` Generic Alogliptin Receives Tentative Approval in US
19 Oct 2018 //
FDA
Kazano® (Alogliptin Benzoate & Metformin Hcl):Takeda V. Indoco Remedies
02 Jan 2018 //
PATENT LITIGATION
Nesina®, Kazano®, & Oseni® : Takeda Pharmaceutical V. Torrent Pharmaceuticals
05 May 2017 //
PATENT LITIGATION
FDA rejects CV outcomes claim for Merck diabetes drugs
11 Apr 2017 //
PHARMA TIMES
Takeda introduces Inisync combo tablets for type 2 diabetes in Japan
30 Nov 2016 //
PHARMABIZ
Takeda`s Nesina doesn`t raise the risk of death in diabetic ACS patients
13 Jun 2016 //
FIERCE PHARMA
Merck`s DPP-4 newcomer Marizev trails Januvia in safety: Report
15 Apr 2016 //
FIERCE PHARMA
FDA warning on J&J`s Invokana adds more complexities to diabetes drug battles
12 Sep 2015 //
FIERCE PHARMA
UPDATED: It`s confirmed: `No signal` of heart failure risk with Merck`s Januvia
31 Aug 2015 //
FIERCE PHARMA
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
29 Aug 2015 //
REUTERS
Record new drug sales give a mega-boost to U.S. drug spending
15 Apr 2015 //
FIERCE PHARMA
AstraZeneca`s Onglyza `Mortality` Risks Noted By FDA Reviewers
13 Apr 2015 //
FIERCE PHARMA
AZ`s Onglyza Has Most to Lose at FDA Safety Confab, Analysts Say
10 Apr 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.